Today: 10 June 2026
Browse Category

NASDAQ:SNGX 27 May 2026

Soligenix Stock Nearly Doubles Before the Bell as Ebola Vaccine Hopes Put Tiny Biotech Back in Play

Soligenix Stock Nearly Doubles Before the Bell as Ebola Vaccine Hopes Put Tiny Biotech Back in Play

Soligenix Inc. shares jumped 94.6% to $1.00 in pre-market trading after linking its ThermoVax technology to the Bundibugyo Ebola outbreak in Congo and Uganda. The WHO declared the outbreak a Public Health Emergency of International Concern, with 105 confirmed cases and 10 deaths in DRC, and seven cases in Uganda. No FDA-approved vaccine exists for Bundibugyo virus. Soligenix has no product orders or revenue.
27 May 2026
·

Stock Market Today

  • S&P 500 Futures Rise on Cooling US Inflation Expectations Amid High Bond Yields
    June 10, 2026, 5:12 AM EDT. US stock futures edged higher, with S&P 500 and Nasdaq contracts up 0.2% to 0.7%, as investors balanced cooler inflation expectations against climbing government bond yields. The US 10-year Treasury yield hovered at 4.57%, keeping borrowing costs elevated. Consumer inflation expectations for the next year declined to 3.5%, signaling easing price pressures. Investors are focused on whether this environment will affect rate-sensitive sectors like real estate and utilities, while growth sectors such as technology remain in focus. Key earnings reports from Oracle, Adobe, and Lennar this week, alongside CPI and PPI inflation data, are expected to guide market sentiment further.

Latest articles

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

LVMH Drops Following Quick Rally, RBC Still Sees Recovery for Luxury

10 June 2026
LVMH shares slipped 0.49% to €489.90 in Paris after a four-day rebound, as investors weighed RBC’s reiterated Buy rating with a €600 target against ongoing 2026 losses and a 24% year-to-date drop; all eyes now turn to July’s first-half results for signs of recovery in Fashion & Leather Goods and any relief from Middle East weakness.
Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

Roche Shares Edge Up After $2.3 Billion Nurix Cancer Pact

10 June 2026
Roche’s participation certificates climbed 1.07% to CHF 322.20 after announcing a $2.3 billion deal with Nurix Therapeutics for late-stage blood-cancer drug bexobrutideg, planned to enter Phase 3 trials this summer in CLL, as investors weigh the asset’s potential to offset losses from expiring patents and drive mid-single-digit sales growth in 2026.
YY Group Shares Jump Premarket on Humanoid Robot Move

YY Group Shares Jump Premarket on Humanoid Robot Move

10 June 2026
YYGH jumped to $0.19 in early pre-market after announcing deployment of Unitree G1 humanoid robots for facility management, aiming to turn operational know-how into higher-margin data assets, but the stock remains volatile near record lows after a recent reverse split and has not confirmed robot-driven revenue or margin gains.
Tencent Shares Gain After $4.66B Bond Sale Seen Fueling AI Bets

Tencent Shares Gain After $4.66B Bond Sale Seen Fueling AI Bets

10 June 2026
Tencent shares jumped 3.22% to HK$467.80 after the company priced a larger-than-expected US$4.66 billion dual-currency bond deal, drawing over US$17 billion in orders and allowing tighter pricing, as investors weighed Tencent’s ability to fund rising AI investments while maintaining strong cash flow and ongoing share buybacks.
PAVS Stock Jumps Again, $195M Share Sale Filing in Focus

PAVS Stock Jumps Again, $195M Share Sale Filing in Focus

10 June 2026
Paranovus Entertainment Technology shares jumped 19.6% premarket after filing plans for an at-the-market share sale of up to $194.99 million—an unusually large amount compared to its $1.07 million market value—raising dilution risks as the company can sell shares at prevailing prices with no minimums, while recent trading has been highly volatile and underlying operations remain limited.
Go toTop